![Paul Thielking](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Thielking is currently Chief Science Officer at Numinus Wellness, Inc. since 2022.
Formerly, Dr. Thielking was Director-Psycho Oncology at Huntsman Cancer Institute, Associate Professor at the University of Utah, and Chief Scientific Officer at Novamind, Inc.
| Unternehmen | Position | Beginn |
|---|---|---|
| NUMINUS WELLNESS INC. | Technik-/Wissenschafts-/F&E-Leiter | 10.06.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Huntsman Cancer Institute | Corporate Officer/Principal | - |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| NOVAMIND INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Numinus Wellness, Inc.
 Numinus Wellness, Inc. Precious MetalsNon-Energy Minerals Operates numinus health, mindspace and psychedelic neurology center | Non-Energy Minerals |
Novamind, Inc.
 Novamind, Inc. Medical/Nursing ServicesHealth Services Provides investment services in infrastructure of psychedelic clinics and retreats | Health Services |
Huntsman Cancer Institute |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
